Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bayer Aktienges ADR (OP:BAYRY)

11.45 +0.30 (+2.69%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bayer Aktienges ADR

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them? ↗
Can the formerly red-hot biotech segment return to its previous glory? 
Via Investor's Business Daily
News headline image
Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer ↗
Aveo Pharmaceuticals Inc (NASDAQ: AVEO) will present new long-term progression-free survival (PFS) data from the Phase 3 TIVO-3 study in kidney cancer at the 2022... 
Via Benzinga
News headline image
Why Are Evotec Shares Trading Lower On Friday? ↗
Bayer AG (OTC: BAYRY) has  
Via Benzinga
News headline image
The Journey To Rewrite Human DNA Is About To Get Wild, Thanks To Pfizer, Bayer, Intellia And Other CRISPR stocks ↗
Big Pharma is paying attention to CRISPR stocks. Could that alight shares this year? 
Via Investor's Business Daily
News headline image
Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer ↗
Pfizer and Bayer inked deals with several companies in gene-editing. 
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table ↗
This article was originally published on The Bluntness, and ... 
Via Benzinga
News headline image
Recursion, Bayer Expand Fibrosis Pact To Include Inferential Search Capabilities ↗
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) expanded its existing strategic collaboration in fibrosis with Bayer AG (OTC: BAYRY). The expanded... 
Via Benzinga
News headline image
Even Good Penny Stocks Like Senseonics Aren’t Always Profitable ↗
Its latest implanted sensor lasts six months, but SENS stock faces competition from Dexcom, Abbott Labs and potentially one big name in tech. 
Via InvestorPlace
News headline image
Bayer's Nubeqa Shows Prolonged Survival In Late-Stage Prostate Cancer Trial ↗
Bayer AG (OTC: BAYRY) said a combination therapy, including its Nubeqa drug, was shown to prolong the lives of men who have metastatic prostate cancer in a clinical... 
Via Benzinga
News headline image
Microsoft, Bayer Collaborate To Develop Digital Agricultural Tools, Capabilities ↗
Microsoft Corp (NASDAQ: MSFT) and Bayer AG (OTC: BAYRY) (OTC: BAYZF) collaborated on new internet-based products aimed at helping farmers and industries... 
Via Benzinga
News headline image
The Secret To Successful Investing In Biotech ↗
Have you ever had a stock jump 30%, 50% or 100% in one day? 
Via Talk Markets
News headline image
Agricultural Technology Companies Are Finding Themselves in a Global Race to Develop and Acquire New Intellectual Property ↗
Image by AgriFORCE The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of Moderna's COVID-19 Vaccine Booster Shot For... 
Via Benzinga
News headline image
Here’s What Happens When You Beat The Market By 5% (And How To Do It) ↗
See, the way Wall Street makes money has fundamentally shifted in recent years. So has the way information flows to individual investors. And today I want to show you how savvy stock pickers can profit... 
Via Talk Markets
News headline image
I See Another “Chipotle Moment” ↗
Lawsuits are terrible for business. They bring distractions, extra costs, and uncertainty. Big Tobacco knows this all too well. 
Via Talk Markets
Topics Lawsuit
News headline image
Acceleron Stock Heats Up On $11 Billion Takeover Rumor; So, Who's The Buyer? ↗
A biotech working in lung and blood diseases, as well as cancer, could be acquired. 
Via Investor's Business Daily
News headline image
BWXT Medical, Bayer AG Ink Agreement On Actinium-225 ↗
BWX Technologies Inc's (NYSE: BWXT) subsidiary BWXT Medical Ltd. has agreed with Bayer AG (OTC: BAYRY) to develop Actinium-225 (Ac-225) supply and... 
Via Benzinga
News headline image
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration ↗
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) revealed new Phase 2 proof-of-concept trial data on Eylea (aflibercept) injection in patients with wet age-related... 
Via Benzinga
News headline image
Berkeley Lights, Bayer Ink Discovery Pact For Next-Gen Traits In Agricultural Sector, Berkeley Q2 Earnings Miss Estimates ↗
Berkeley Lights Inc (NASDAQ: BLI) reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million. The Company expanded the installed... 
Via Benzinga
Topics Earnings
News headline image
3 Pharma Stocks to Buy in August ↗
These stocks offer solid growth opportunities. 
Via The Motley Fool
News headline image
Bristol Myers Pulls Accelerated Approval For Opdivo In Post-Nexavar Liver Cancer ↗
Bristol Myers Squibb & Co (NYSE: BMY) on Friday said it's voluntarily withdrawing Opdivo's approval in hepatocellular carcinoma (HCC) patients who... 
Via Benzinga
News headline image
The Cloud Sector Can Drive Your Profits Sky High ↗
If you hear someone suggesting you invest in “containers,” please don’t get confused. Most folks would naturally think of these as giant metal shipping boxes that are integral for global trade. 
Via Talk Markets
News headline image
Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod ↗
The European Commission (EC) has approved Merck & Co Inc's (NYSE: MRK) soluble guanylate cyclase (sGC) stimulator Verquvo (vericiguat). Verquvo... 
Via Benzinga
News headline image
Bayer's Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes ↗
The FDA on Friday approved Bayer AG's (OTC: BAYRY) chronic kidney disease (CKD) drug Kerendia (finerenone), the first and only nonsteroidal mineralocorticoid... 
Via Benzinga
News headline image
3 Top Biotech Stocks to Buy in July ↗
Now's the time to get into these companies while their valuation is still favorable. 
Via The Motley Fool
News headline image
3 Big Drugmakers to Buy Ahead of the Q2 Earnings Season ↗
The big drug companies are set for the second-quarter earnings season, which begins later this month. 
Via Talk Markets
News headline image
Cloud Stocks Change Name Of The Cloud Computing Game With 'Containers' From Amazon, Microsoft, Alphabet's Google ↗
Amazon, Microsoft and Google are promoting a model that may expand cloud computing. 
Via Investor's Business Daily
News headline image
Why Did Novocure Shares Plunge Today? ↗
Novocure Ltd (NASDAQ: NVCR) has announced final results from its phase 2 pilot HEPANOVA trial evaluating Tumor Treating Fields (TTFields) together with Bayer... 
Via Benzinga
News headline image
Exelixis Shares Drop On Mixed Results For Cabometyx Combo In Early Liver Cancer ↗
Exelixis Inc (NASDAQ: EXEL) and Ipsen (OTC: IPSEY) have announced mixed interim results from the COSMIC-312 Phase 3 trial evaluating cabozantinib (... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.